in a multicenter , evaluator-blind , parallel group study of 244 patients with moderate to severe psoriasis , a once-daily application of a new formulation of beta-methasone dipropionate 0.05 % cream , augmented formulation ( af ) , and a twice-daily application of fluocinonide 0.05 % cream were compared , with respect to safety and efficacy .
C0033860
psoriasis
C0775571
beta-methasone dipropionate 0.05